Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure

Michael W Brands, M. Alonso-Galicia, H. L. Mizelle, J. P. Montani, D. A. Hildebrandt, J. E. Hall

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The purpose of this study was to examine the sequential changes in renal and cardiovascular function produced by chronic Benazepril administration at different stages of heart failure in dogs. Heart failure was produced by rapid ventricular pacing in five dogs with a normally functioning renin- angiotensin system (angiotensin normal, AN) and six dogs chronically administered the angiotensin-converting-enzyme inhibitor (ACEI) Benazepril. After 7 days of pacing, cardiac output was significantly higher and total peripheral resistance (TPR) lower in the ACEI compared with the AN dogs. Cumulative sodium and water balance increased significantly in both groups, but after 7 days of pacing there were no significant differences between groups. However, the rate of increase in sodium and water balance was significantly less in the ACEI group. Effective renal plasma flow decreased in the AN and ACEI groups during pacing, but there were no between-group differences, and no significant changes in glomerular filtration rate (GFR) occurred in either group. In the AN dogs, pacing was continued for 7-21 days until the onset of decompensated heart failure. Urinary sodium excretion increased on the first day of ACEI infusion during this stage but returned to pre-ACEI levels during the next 2-3 days. No significant improvement in cardiac output was measured during ACEI in decompensated heart failure. These data suggest that chronic ACEI administration can improve renal and cardiac function in early heart failure without impairing GFR but is less effective in later, decompensated stages.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume264
Issue number2 33-2
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Water-Electrolyte Balance
Peptidyl-Dipeptidase A
Angiotensin-Converting Enzyme Inhibitors
Cardiac Output
Heart Failure
Angiotensins
Dogs
Sodium
Glomerular Filtration Rate
Effective Renal Plasma Flow
Kidney
Water
Renin-Angiotensin System
Vascular Resistance

Keywords

  • angiotensin II
  • arterial pressure
  • glomerular filtration rate
  • sodium excretion
  • total peripheral resistance

ASJC Scopus subject areas

  • Physiology

Cite this

Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure. / Brands, Michael W; Alonso-Galicia, M.; Mizelle, H. L.; Montani, J. P.; Hildebrandt, D. A.; Hall, J. E.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 264, No. 2 33-2, 01.01.1993.

Research output: Contribution to journalArticle

@article{bc24d389acf04b26b6e76cdb0e7dbf96,
title = "Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure",
abstract = "The purpose of this study was to examine the sequential changes in renal and cardiovascular function produced by chronic Benazepril administration at different stages of heart failure in dogs. Heart failure was produced by rapid ventricular pacing in five dogs with a normally functioning renin- angiotensin system (angiotensin normal, AN) and six dogs chronically administered the angiotensin-converting-enzyme inhibitor (ACEI) Benazepril. After 7 days of pacing, cardiac output was significantly higher and total peripheral resistance (TPR) lower in the ACEI compared with the AN dogs. Cumulative sodium and water balance increased significantly in both groups, but after 7 days of pacing there were no significant differences between groups. However, the rate of increase in sodium and water balance was significantly less in the ACEI group. Effective renal plasma flow decreased in the AN and ACEI groups during pacing, but there were no between-group differences, and no significant changes in glomerular filtration rate (GFR) occurred in either group. In the AN dogs, pacing was continued for 7-21 days until the onset of decompensated heart failure. Urinary sodium excretion increased on the first day of ACEI infusion during this stage but returned to pre-ACEI levels during the next 2-3 days. No significant improvement in cardiac output was measured during ACEI in decompensated heart failure. These data suggest that chronic ACEI administration can improve renal and cardiac function in early heart failure without impairing GFR but is less effective in later, decompensated stages.",
keywords = "angiotensin II, arterial pressure, glomerular filtration rate, sodium excretion, total peripheral resistance",
author = "Brands, {Michael W} and M. Alonso-Galicia and Mizelle, {H. L.} and Montani, {J. P.} and Hildebrandt, {D. A.} and Hall, {J. E.}",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "264",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2 33-2",

}

TY - JOUR

T1 - Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure

AU - Brands, Michael W

AU - Alonso-Galicia, M.

AU - Mizelle, H. L.

AU - Montani, J. P.

AU - Hildebrandt, D. A.

AU - Hall, J. E.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The purpose of this study was to examine the sequential changes in renal and cardiovascular function produced by chronic Benazepril administration at different stages of heart failure in dogs. Heart failure was produced by rapid ventricular pacing in five dogs with a normally functioning renin- angiotensin system (angiotensin normal, AN) and six dogs chronically administered the angiotensin-converting-enzyme inhibitor (ACEI) Benazepril. After 7 days of pacing, cardiac output was significantly higher and total peripheral resistance (TPR) lower in the ACEI compared with the AN dogs. Cumulative sodium and water balance increased significantly in both groups, but after 7 days of pacing there were no significant differences between groups. However, the rate of increase in sodium and water balance was significantly less in the ACEI group. Effective renal plasma flow decreased in the AN and ACEI groups during pacing, but there were no between-group differences, and no significant changes in glomerular filtration rate (GFR) occurred in either group. In the AN dogs, pacing was continued for 7-21 days until the onset of decompensated heart failure. Urinary sodium excretion increased on the first day of ACEI infusion during this stage but returned to pre-ACEI levels during the next 2-3 days. No significant improvement in cardiac output was measured during ACEI in decompensated heart failure. These data suggest that chronic ACEI administration can improve renal and cardiac function in early heart failure without impairing GFR but is less effective in later, decompensated stages.

AB - The purpose of this study was to examine the sequential changes in renal and cardiovascular function produced by chronic Benazepril administration at different stages of heart failure in dogs. Heart failure was produced by rapid ventricular pacing in five dogs with a normally functioning renin- angiotensin system (angiotensin normal, AN) and six dogs chronically administered the angiotensin-converting-enzyme inhibitor (ACEI) Benazepril. After 7 days of pacing, cardiac output was significantly higher and total peripheral resistance (TPR) lower in the ACEI compared with the AN dogs. Cumulative sodium and water balance increased significantly in both groups, but after 7 days of pacing there were no significant differences between groups. However, the rate of increase in sodium and water balance was significantly less in the ACEI group. Effective renal plasma flow decreased in the AN and ACEI groups during pacing, but there were no between-group differences, and no significant changes in glomerular filtration rate (GFR) occurred in either group. In the AN dogs, pacing was continued for 7-21 days until the onset of decompensated heart failure. Urinary sodium excretion increased on the first day of ACEI infusion during this stage but returned to pre-ACEI levels during the next 2-3 days. No significant improvement in cardiac output was measured during ACEI in decompensated heart failure. These data suggest that chronic ACEI administration can improve renal and cardiac function in early heart failure without impairing GFR but is less effective in later, decompensated stages.

KW - angiotensin II

KW - arterial pressure

KW - glomerular filtration rate

KW - sodium excretion

KW - total peripheral resistance

UR - http://www.scopus.com/inward/record.url?scp=0027476950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027476950&partnerID=8YFLogxK

M3 - Article

C2 - 8447498

AN - SCOPUS:0027476950

VL - 264

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 2 33-2

ER -